Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma.
Mellors PW, Binder M, Ketterling RP, Greipp PT, Baughn LB, Peterson JF, Jevremovic D, Pearce KE, Buadi FK, Lacy MQ, Gertz MA, Dispenzieri A, Hayman SR, Kapoor P, Gonsalves WI, Hwa YL, Fonder A, Hobbs M, Kourelis T, Warsame R, Lust JA, Leung N, Go RS, Kyle RA, Rajkumar SV, Kumar SK.
Mellors PW, et al.
Blood Adv. 2020 May 26;4(10):2236-2244. doi: 10.1182/bloodadvances.2019001275.
Blood Adv. 2020.
PMID: 32442300
Free PMC article.
Clinical Trial.